ALXN
Alexion Pharmaceuticals Inc
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
818 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals Inc in 2020 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 238 increasing their positions, 283 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
818
Holders Change
+115
Holders Change %
+16.36%
% of All Funds
14.51%
Holding in Top 10
46
Holding in Top 10 Change
+28
Holding in Top 10 Change %
+155.56%
% of All Funds
0.82%
New
202
Increased
238
Reduced
283
Closed
80
Calls
$559M
Puts
$436M
Net Calls
+$123M
Net Calls Change
+$163M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$982M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
$367M |
| 3 |
O
OrbiMed
New York
|
$26.4M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$240M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
$58.6M |
